retatrutide ly3437943 glp-1 gip glucagon Biggest obesity news 🚨 TRIUMPH-1 results are here: Retatrutide's phase 3 trial showed up to 28% average weight loss over 80 weeks — with nearly half of patients losing over 30% of Retatrutide vs. Ozempic

Taken together Tirzepatide shows that a preferential activation of GIPR over GLP1R is capable of producing large decreases in weight without severely increasing side effects

Keep your healthcare provider in the loop

Another large study involving selenium combined with vitamin E for at least 100 days observed differences in sperm morphology, motility, and antioxidant status

More receptor activation in the stomach and intestines means slower stomach emptying, which is already the primary mechanism of action

GHK-Cu in Skin and Hair Rejuvenation. Clinical Dermatology and Peptide Therapy

Most rodent studies used: 10 micrograms/kg 100 micrograms/kg Administration routes varied by study: Intraperitoneal injection Subcutaneous injection Oral administration in drinking water Example reference: Sikiric et al., 2018 These dosages reflect controlled laboratory conditions and are not generalised outside experimental models